tradingkey.logo
搜索

Prenetics Global Ltd

PRE
添加自选
16.930USD
-0.960-5.37%
收盘 07/02, 13:00美东报价延迟15分钟
287.82M总市值
亏损市盈率 TTM

Prenetics Global Ltd

16.930
-0.960-5.37%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-5.37%

5天

-10.09%

1月

-18.57%

6月

+7.29%

今年开始到现在

+7.49%

1年

+111.63%

关键数据
18.040今开
19.365最高
122.28K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.72%换手率
17.890昨收
16.590最低
1.37M成交额
亏损市盈率静
2.38市净率
0.00%股息率 TTM
-17.27%ROA
23.63052周最高
2.02量比
-46.30M净利润
17.00M总股本
-2.6835每股收益TTM
0.21Beta
-20.79%ROE
5.58052周最低
15.51%振幅
64.76%毛利率
287.82M总市值
-2.72回报/风险
5.12%风险率

TradingKey Prenetics Global Ltd股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Prenetics Global Ltd当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名114/387位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价31.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Prenetics Global Ltd评分

相关信息

行业排名
114 / 387
全市场排名
238 / 4565
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

Prenetics Global Ltd亮点

亮点风险
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
业绩高增长
公司营业收入稳步增长,连续3年增长324.92%
业绩增长期
公司处于发展阶段,最新年度总收入92.39M美元
估值低估
公司最新PE估值-6.31,处于3年历史低位
机构减仓
最新机构持股1.76M股,环比减少30.62%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00

分析师目标

根据 3 位分析师
买入
评级
31.000
目标均价
+73.28%
涨幅空间

Prenetics Global Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Prenetics Global Ltd简介

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
公司代码PRE
公司Prenetics Global Ltd
CEOKwok (Samantha)
网址https://ir.prenetics.com/

常见问题

Prenetics Global Ltd(PRE)的当前股价是多少?

Prenetics Global Ltd(PRE)的当前股价是 16.93。

Prenetics Global Ltd的股票代码是什么?

Prenetics Global Ltd的股票代码是PRE。

Prenetics Global Ltd股票的52周最高点是多少?

Prenetics Global Ltd股票的52周最高点是23.63。

Prenetics Global Ltd股票的52周最低点是多少?

Prenetics Global Ltd股票的52周最低点是5.58。

Prenetics Global Ltd的市值是多少?

Prenetics Global Ltd的市值是287.82M。

现在Prenetics Global Ltd(PRE)的股票是买入、持有还是卖出?

根据分析师评级,Prenetics Global Ltd(PRE)的总体评级为买入,目标价格为31.00。

Prenetics Global Ltd(PRE)股票的每股收益(EPS TTM)是多少

Prenetics Global Ltd(PRE)股票的每股收益(EPS TTM)是-2.68。